Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Sellers

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Cell|October 4, 2011
A blueprint for advancing genetics-based cancer therapyWilliam R Sellers
Nature Reviews. Drug Discovery|March 2, 2011
Advances in the preclinical testing of cancer therapeutic hypothesesGiordano Caponigro, William R Sellers
Cancer Cell|November 27, 2002
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?William R Sellers, Massimo Loda
Cancer Research|December 2, 2021
Are CRISPR Screens Providing the Next Generation of Therapeutic Targets?Francisca Vazquez, William R Sellers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
The biology and clinical relevance of the PTEN tumor suppressor pathwayIsabelle Sansal, William R Sellers
Current Opinion in Cell Biology|March 31, 2009
Linking somatic genetic alterations in cancer to therapeuticsDarrin Stuart, William R Sellers
Nature Reviews. Cancer|July 25, 2006
Lineage dependency and lineage-survival oncogenes in human cancerLevi A Garraway, William R Sellers
The Journal of Urology|November 12, 2003
Use of expression analysis to predict outcome after radical prostatectomyPhillip G Febbo, William R Sellers
Cancer Research|March 3, 2006
From integrated genomics to tumor lineage dependencyLevi A Garraway, William R Sellers
Oncogene|November 17, 2005
Akt-regulated pathways in prostate cancerPradip K Majumder, William R Sellers
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Cell|October 4, 2011
A blueprint for advancing genetics-based cancer therapyWilliam R Sellers
Nature Reviews. Drug Discovery|March 2, 2011
Advances in the preclinical testing of cancer therapeutic hypothesesGiordano Caponigro, William R Sellers
Cancer Cell|November 27, 2002
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?William R Sellers, Massimo Loda
Cancer Research|December 2, 2021
Are CRISPR Screens Providing the Next Generation of Therapeutic Targets?Francisca Vazquez, William R Sellers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
The biology and clinical relevance of the PTEN tumor suppressor pathwayIsabelle Sansal, William R Sellers
Current Opinion in Cell Biology|March 31, 2009
Linking somatic genetic alterations in cancer to therapeuticsDarrin Stuart, William R Sellers
Nature Reviews. Cancer|July 25, 2006
Lineage dependency and lineage-survival oncogenes in human cancerLevi A Garraway, William R Sellers
The Journal of Urology|November 12, 2003
Use of expression analysis to predict outcome after radical prostatectomyPhillip G Febbo, William R Sellers
Cancer Research|March 3, 2006
From integrated genomics to tumor lineage dependencyLevi A Garraway, William R Sellers
Oncogene|November 17, 2005
Akt-regulated pathways in prostate cancerPradip K Majumder, William R Sellers
Pageof 17